Cross-Practice Faegre Drinker Team Represents Surmodics in Acquisition Agreement
June 11, 2024
June 11, 2024
MINNEAPOLIS, Minnesota, June 11 -- Faegre Drinker, a law firm, issued the following news release:
A Faegre Drinker team led by corporate partners Mike Stanchfield, Brandon Mason and Nicole Leimer represented client Surmodics, Inc. -- a provider of medical device and in vitro diagnostic technologies to the health care industry -- in its entering into a definitive agreement to be acquired by GTCR, a private equity firm.
Surmodics shareholders will receive $43.00 per shar . . .
A Faegre Drinker team led by corporate partners Mike Stanchfield, Brandon Mason and Nicole Leimer represented client Surmodics, Inc. -- a provider of medical device and in vitro diagnostic technologies to the health care industry -- in its entering into a definitive agreement to be acquired by GTCR, a private equity firm.
Surmodics shareholders will receive $43.00 per shar . . .